Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test

被引:35
作者
Legesse, Mengistu [1 ,3 ]
Ameni, Gobena [1 ]
Mamo, Gezahegne [2 ,3 ]
Medhin, Girmay [1 ]
Bjune, Gunnar [3 ]
Abebe, Fekadu [3 ]
机构
[1] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia
[2] Univ Addis Ababa, Fac Vet Med, Beshofitu, Ethiopia
[3] Univ Oslo, Dept Gen Practice & Community Med, Inst Hlth & Soc, Oslo, Norway
关键词
INTERFERON RELEASE ASSAY; HEALTH-CARE WORKERS; GAMMA ASSAY; DIAGNOSIS; PREVALENCE; PERFORMANCE; SETTINGS; CONTACT; CELLS; RATES;
D O I
10.1186/1471-2334-11-89
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: There is little information concerning community-based prevalence of latent tuberculosis infection (LTBI) using T-cell based interferon-g (IFN-gamma) release assays (IGRAs), particularly in TB endemic settings. In this study, the prevalence of LTBI in the Afar pastoral community was assessed using QuantiFERON-TB Gold In-Tube (QFTGIT) and tuberculin skin tests (TST). Methods: A community-based cross-sectional survey of LTBI involving 652 apparently healthy adult pastoralists was undertaken in the pastoral community of Amibara District of the Afar Region between April and June 2010. Results: The prevalence of LTBI was estimated as 63.7% (363/570) using QFTGIT at the cut-off point recommended by the manufacturer (>= 0.35 IU/ml IFN-gamma), while it was 74.9% (427/570) using a cut-off point >= 0.1 IU/ml IFN-gamma. The QFTGIT-based prevalence of LTBI was not significantly associated with the gender or age of the study participants. However, the prevalence of LTBI was 31.2% (183/587) using TST at a cut-off point >= 10 mm of skin indurations, and it was higher in males than females (36.8% vs. 23.5%, X-2 = 11.76; p < 0.001). There was poor agreement between the results of the tests (k = 0.098, 95% CI, 0.08 - 0.13). However, there was a positive trend between QFTGIT and TST positivity (X-2 = 96.76, P < 0.001). Furthermore, individuals with skin indurations = 10 mm were 13.6 times more likely to have positive results using QFTGIT than individuals with skin indurations of 0 mm (adjusted OR = 13.6; 95% CI, 7.5 to 24.7, p < 0.001). Conclusions: There is currently no agreed gold standard for diagnosis of LTBI. However, the higher prevalence of LTBI detected using QFTGIT rather than TST suggests that QFTGIT could be used for epidemiological studies concerning LTBI at the community level, even in a population unreactive to TST. Further studies of adults and children will be required to assess the effects of factors such as malnutrition, non-tuberculosis mycobacterial infections, HIV and parasitic infections on the performance of QFTGIT.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Agreement Between Quantiferon-TB Gold Test and Tuberculin Skin Test in the Identification of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    Inanc, Nevsun
    Aydin, Sibel Zehra
    Karakurt, Sait
    Atagunduz, Pamir
    Yavuz, Sule
    Direskeneli, Haner
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) : 2675 - 2681
  • [42] Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON®-TB Gold In-Tube test and tuberculin skin test
    Duman, Nilay
    Ersoy-Evans, Sibel
    Karadag, Omer
    Ascioglu, Sibel
    Sener, Burcin
    Kiraz, Sedat
    Sahin, Sedef
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (10) : 1286 - 1292
  • [43] QuantiFERON-TB Gold Plus evaluation for latent tuberculosis infection among Italian healthcare workers: a cross-sectional study
    Coppeta, Luca
    Baldi, Savino
    Somma, Giuseppina
    Tursi, Elisabetta
    Policardo, Sara
    Balbi, Ottavia
    Lieto, Piergiorgio
    Pietroiusti, Antonio
    Magrini, Andrea
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2019, 16 (02)
  • [44] QuantiFERON-TB Gold In-Tube TEST IN THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN ARTHRITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ANTAGONISTS
    Baricevic, Denis
    Grle, Sanja Popovic
    Vergles, Jadranka Morovic
    Cavka, Silvija Cukovic
    Jakopovic, Marko
    Redzepi, Gzim
    Boras, Zagorka
    Baricevic, Marinka
    Samarzija, Miroslav
    ACTA CLINICA CROATICA, 2017, 56 (02) : 203 - 209
  • [45] Nomogram to determine predictive risk for active tuberculosis based on the QuantiFERON-TB Gold In-Tube test
    Wang, Qiang
    Zhu, Fengdan
    Cai, Yanjuan
    Zhu, Tao
    Lu, Xiaolan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] The use of Quantiferon-TB gold in-tube test in screening latent tuberculosis among Saudi Arabia dialysis patients
    Al Wakeel, Jamal Saleh
    Makoshi, Ziyad
    Al Ghonaim, Mohammed
    Al Harbi, Ali
    Al Suwaida, Abdulkareem
    Algahtani, Farjah
    Al Hedaithy, Mogbil
    Almogairin, Sultan
    Abdullah, Sami
    ANNALS OF THORACIC MEDICINE, 2015, 10 (04) : 284 - 288
  • [47] Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting
    Birku, Mahlet
    Desalegn, Girmay
    Kassa, Getachew
    Tsegaye, Aster
    Abebe, Markos
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 235 - 242
  • [48] QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case
    Rutherford, M. E.
    Nataprawira, M.
    Yulita, I.
    Apriani, L.
    Maharani, W.
    van Crevel, R.
    Hill, P. C.
    Alisjahbana, B.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (04) : 496 - 502
  • [49] Evaluation of QuantiFERON®-TB Gold in Tube Test and Tuberculin Skin Test in the Diagnosis of Mycobacterium tuberculosis Infection
    Cavusoglu, Cengiz
    Durusoy, Raika
    Yasar, Melike
    Kayin, Munevver
    MIKROBIYOLOJI BULTENI, 2017, 51 (02): : 115 - 126
  • [50] Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran
    Mostafavi, Ehsan
    Nasehi, Mahshid
    Shahraki, Abdolrazagh Hashemi
    Esmaeili, Saber
    Ghaderi, Ebrahim
    Sharafi, Saeed
    Doosti-Irani, Amin
    EPIDEMIOLOGY AND HEALTH, 2016, 38